Everlab raises $65M Series A, plans UK expansion and hiring
Melbourne preventive health startup Everlab closed a $65 million Series A led by Airtree Ventures. The round included UK fund Plural, Europe's b2venture, existing investor Left Lane Capital, and Australian test captain Pat Cummins.
The company raised $3 million pre-seed in December 2023, launched publicly in January 2024, then closed a $15 million seed round in July 2025. Total funding now sits at $83 million across three rounds in 18 months.
What they do
Everlab sells AI-powered preventive health diagnostics: biomarker testing, whole-body MRI scans, and personalised prevention plans. Pricing ranges from $299 for basic health checks to $3,499 for full-body MRI. Packaged assessments run $900 to $2,700.
The company has analysed 20,000+ clients across Australia and New Zealand (launched last month). They claim more than 25% of clients had previously undetected health issues spotted during testing.
Corporate wellness play
Everlab runs executive health programmes for Boston Consulting Group, BHP and Bain & Company. The platform integrates with 1,850+ health provider locations, 180+ active clinicians and 30+ wearable devices, processing 200,000+ health reports monthly.
This suggests a dual go-to-market strategy: direct-to-consumer subscription plus enterprise wellness contracts. No public revenue figures or sales team headcount disclosed.
What the money funds
UK market expansion is first priority. The company is also hiring for clinical and technology infrastructure. Expect roles across sales, account management, clinical operations and AI/engineering teams in both Melbourne and London.
Competitors in the preventive health space include Compound and Superpower, though Everlab's corporate wellness contracts differentiate their positioning.
CEO Marc Hermann previously co-founded Foodspring, which Mars acquired in 2019. Other Everlab co-founders: Dr Steven Lu, Sam Kothari and Anshul Jain.
For sales professionals: watch for UK-based AE and AM roles as they build out the London operation. Corporate wellness sales likely requires enterprise experience and healthcare/benefits knowledge.